Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluoSCOPE and ICG for Sentinel Lymph Node Mapping in Lung Cancer
NCT02423148Withdrawn
- Sponsor
- Dana-Farber Cancer Institute
- Start
- May 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of indocyanine green in lung cancer, sponsored by Dana-Farber Cancer Institute. Primary endpoint: Sentinel lymph node(s) identified via NIR fluorescence imaging at Day 1. Planned start May 2015; status: withdrawn.
02
Drugs
indocyanine green
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT02423148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02423148.